Inner Harbor-based biotech company PathSensors will be acquired by global security screening and threat detection company Smiths Detection, the companies announced this week.
With the deal, PathSensors will become part of a London-based company with 2,200 employees and a U.S. headquarters in Edgewood.
Built on genetically engineered cell technology developed at MIT’s Lincoln Laboratories called CANARY, PathSensors’ products test for the presence of disease-causing agents, aka pathogens, in a specific environment in minutes. The technology was originally developed to test for bioterrorism threats, where it is currently used by defense and homeland security.
READ FULL ARTICLE HERE
